Charles River says not named or referenced in DOJ proceedings

In a regulatory filing, Charles River said that during its presentation at Evercore ISI 5th Annual HealthCONx Conference, management will address the topic of non-human primate supply following the November 16, 2022 announcement by the U.S. Department of Justice through the U.S. Attorney’s Office for the Southern District of Florida that a Cambodian NHP supplier and two Cambodian officials had been criminally charged in connection with illegally importing NHPs into the U.S. "In particular, in recognition of the numerous investment analyst and media reports related to NHP pricing, the NHP supply chain, and the DOJ proceedings, the Company made statements to the following effect: a.Charles River was not named or referenced in the DOJ proceedings, and the Company does not have any direct supply contracts with the indicted Cambodian supplier. b.Charles River has global supply sources, including other sources in Cambodia, which is the primary country of origin of NHP imports to the United States and to Charles River. However, in light of the indictment, and subsequent statements made by the Cambodia government, Charles River is operating under the expectation that for some time period supply of Cambodia-sourced NHPs will be difficult to obtain in the United States; and c.The Company is diligently working to mitigate any Cambodia NHP supply impact with ongoing efforts to procure NHPs under different supply arrangements and from other global sources."